Otonomy to Report Fourth Quarter and Full Year 2014 Financial Results and Provide Corporate Update
March 12 2015 - 8:00AM
Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical
company focused on the development and commercialization of
innovative therapeutics for diseases and disorders of the inner and
middle ear, today announced it will report financial results for
the fourth quarter and full year 2014 as well as provide a
corporate update at 4:30 p.m. ET on March 18, 2015.
The live call may be accessed by dialing (866) 953-6857
(domestic) or (617) 399-3481 (international). A live webcast of the
call will be available online on the investor relations section of
Otonomy's website at www.otonomy.com and will be archived there for
30 days. A telephone replay of the call will be available by
dialing (888) 286-8010 (domestic) or (617) 801-6888 (international)
and entering the conference code 90772974.
About Otonomy
Otonomy is a clinical-stage biopharmaceutical company focused on
the development and commercialization of innovative therapeutics
for diseases and disorders of the ear. Otonomy's proprietary
technology provides sustained exposure of drugs to the middle and
inner ear following a single intratympanic injection. Otonomy has
three product candidates in development. AuriPro™ is an antibiotic
that has completed Phase 3 clinical trials in pediatric patients
with middle ear effusion at the time of tympanostomy tube placement
surgery. A New Drug Application for AuriPro has been submitted to
the FDA. OTO-104 is a steroid that is in the first of two pivotal
clinical studies for the treatment of patients with Ménière's
disease. OTO-311 is an NMDA receptor antagonist in development as a
treatment for tinnitus. For additional information please visit
www.otonomy.com.
CONTACT: Media Inquiries
Canale Communications
Heidi Chokeir, Ph.D.
Vice President
619.849.5377
heidi@canalecomm.com
Investor Inquiries
Westwicke Partners
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024